(Q44324366)

2 December 2017

title

Effect of therapeutic drug monitoring on outcome in antiretroviral experienced HIV-infected individuals (English)

1 reference

2 December 2017

Patrick W G Mallon

1

1 reference

2 December 2017

John Ray

series ordinal

2

1 reference

2 December 2017

David A Cooper

series ordinal

3

1 reference

2 December 2017

publication date

1 February 2003

1 reference

Journal of Clinical Virology

2 December 2017

published in

1 reference

2 December 2017

volume

26

1 reference

2 December 2017

issue

2

1 reference

2 December 2017

page(s)

223-227

1 reference

Paronychia in association with indinavir treatment

2 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900120-8

7 January 2021

Drug resistance and predicted virologic responses to human immunodeficiency virus type 1 protease inhibitor therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900120-8

7 January 2021

Efavirenz-induced decrease in plasma amprenavir levels in human immunodeficiency virus-infected patients and correction by ritonavir

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900120-8

7 January 2021

Drug susceptibility in HIV infection after viral rebound in patients receiving indinavir-containing regimens

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900120-8

7 January 2021

Reliability of Cmin: inhibitory concentration ratios

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900120-8

7 January 2021

Efavirenz plasma levels can predict treatment failure and central nervous system side effects in HIV-1-infected patients

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900120-8

7 January 2021

Saquinavir pharmacokinetics alone and in combination with ritonavir in HIV-infected patients

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900120-8

7 January 2021

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900120-8

7 January 2021

Adherence to protease inhibitor therapy and outcomes in patients with HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900120-8

7 January 2021

Determination of serum levels of thirteen human immunodeficiency virus-suppressing drugs by high-performance liquid chromatography

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900120-8

7 January 2021

10.1016/S1386-6532(02)00120-8

Identifiers

DOI

1 reference

2 December 2017

1 reference